B7-H4's role "beyond the Tumor"

Inflammation

Volumn 36, Issue 4, 2013, Pages 941-947

  Li, Xiangpei ^a   Yu, Ning ^a   Li, Xiaomei ^a   Zheng, Songguo ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

B7 H4; costimulatory molecule; immune

Indexed keywords

CONCANAVALIN A; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONSERVATION BIOLOGY; CYTOKINE PRODUCTION; DOWN REGULATION; LIVER INJURY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PUFFER FISH; REGULATORY T LYMPHOCYTE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; FAS LIGAND PROTEIN; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; LYMPHOCYTES; MACROPHAGES; MICE; NEOPLASMS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84880274377     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9624-0     Document Type: Article

References (54)

1. Wang, S.; and L. Chen. 2004. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses. Microbes Infect 6: 759-766.
2. Sica, G.L.; I.H. Choi, G. Zhu, K. Tamada, S.D. Wang, H. Tamura, A.I. Chapoval, D.B. Flies, J. Bajorath, and L. Chen. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. In Immunity, 2003/06/24 ed. 849-861.
3. Park, G.B.; H. Song, Y.S. Kim, M. Sung, J.W. Ryu, H.K. Lee, D.H. Cho, D. Kim, W.J. Lee, and D.Y. Hur. 2009. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines. Immunology 128: 360-368.
4. Ou, D.; X. Wang, D.L. Metzger, Z. Ao, P. Pozzilli, R.F. James, L. Chen, and G.L. Warnock. 2006. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant 15: 399-410.
5. Yuan, C.L.; J.F. Xu, J. Tong, H. Yang, F.R. He, Q. Gong, P. Xiong, L. Duan, M. Fang, Z. Tan, Y. Xu, Y.F. Chen, F. Zheng, and F.L. Gong. 2009. B7-H4 transfection prolongs beta-cell graft survival. Transpl Immunol 21: 143-149.
6. Yamaura, K.; T. Watanabe, O. Boenisch, M. Yeung, S. Yang, C.N. Magee, R. Padera, S. Datta, T. Schatton, Y. Kamimura, M. Azuma, and N. Najafian. 2010. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses. Am J Transplant 10: 2355-2362.
7. Azuma, T.; G. Zhu, H. Xu, A.C. Rietz, C.G. Drake, E.L. Matteson, and L. Chen. 2009. Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: A mouse model informed by clinical data. PLoS Med 6: e1000166.
8. Guo, G.; Y. Shang, G. Zhu, X. Bao, S. Xu, and Y. Chen. 2011. The expression and distribution of immunomodulatory proteins B7-H1, B7-DC, B7-H3, and B7-H4 in rheumatoid synovium. Clin Rheumatol. 31(2): 271-81.
9. Chen, Y.; G. Guo, S. Guo, S. Shimoda, K.R. Shroyer, Y. Tang, and Y. Wu. 2010. Intracellular B7-H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis. Inflammation. 34(6): 688-97.
10. Collins, M.; V. Ling, and B.M. Carreno. 2005. The B7 family of immune-regulatory ligands. Genome Biol 6: 223.
11. Wang, S.; and L. Chen. 2004. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell Mol Immunol 1: 37-42.
12. Carreno, B.M.; and M. Collins. 2002. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20: 29-53.
13. Prasad, D.V.; S. Richards, X.M. Mai, and C. Dong. 2003. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 18(6): 863-873.
14. Sugamata, R.; H. Suetake, K. Kikuchi, and Y. Suzuki. 2009. Teleost B7 expressed on monocytes regulates T cell responses. J Immunol 182: 6799-6806.
15. Zang, X.; P. Loke, J. Kim, K. Murphy, R. Waitz, and J.P. Allison. 2003. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A 100: 10388-10392.
16. Choi, I.H.; G. Zhu, G.L. Sica, S.E. Strome, J.C. Cheville, J.S. Lau, Y. Zhu, D.B. Flies, K. Tamada, and L. Chen. 2003. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 171: 4650-4654.
17. Salceda, S.; T. Tang, M. Kmet, A. Munteanu, M. Ghosh, R. Macina, W. Liu, G. Pilkington, and J. Papkoff. 2005. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 306: 128-141.
18. Yi, K.H.; and L. Chen. 2009. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 229: 145-151.
19. Tringler, B.; S. Zhuo, G. Pilkington, K.C. Torkko, M. Singh, M.S. Lucia, D.E. Heinz, J. Papkoff, and K.R. Shroyer. 2005. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 11: 1842-1848.
20. Kamimura, Y.; H. Kobori, J. Piao, M. Hashiguchi, K. Matsumoto, S. Hirose, and M. Azuma. 2009. Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses. Biochem Biophys Res Commun 389: 349-353.
21. Watanabe, N.; M. Gavrieli, J.R. Sedy, J. Yang, F. Fallarino, S.K. Loftin, M.A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T.L. Murphy, J.H. Russell, J.P. Allison, and K.M. Murphy. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4: 670-679.
22. Carreno, B.M.; and M. Collins. 2003. BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol 24: 524-527.
23. Sedy, J.R.; M. Gavrieli, K.G. Potter, M.A. Hurchla, R.C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C.F. Ware, T.L. Murphy, and K.M. Murphy. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6: 90-98.
24. Xue, Q.; X.Y. Luan, Y.Z. Gu, H.Y. Wu, G.B. Zhang, G.H. Yu, H.T. Zhu, M. Wang, W. Dong, Y.J. Geng, and X.G. Zhang. 2010. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells Dev 19: 27-38.
25. Chen, Y.; C. Yang, Z. Xie, L. Zou, Z. Ruan, X. Zhang, Y. Tang, L. Fei, Z. Jia, and Y. Wu. 2006. Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells. Kidney Int 70: 2092-2099.
26. Tringler, B.; W. Liu, L. Corral, K.C. Torkko, T. Enomoto, S. Davidson, M.S. Lucia, D.E. Heinz, J. Papkoff, and K.R. Shroyer. 2006. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 100: 44-52.
27. Simon, I.; D. Katsaros, I. Rigault de la Longrais, M. Massobrio, A. Scorilas, N.W. Kim, M.J. Sarno, R.L. Wolfert, and E.P. Diamandis. 2007. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. Gynecol Oncol 106: 334-341.
28. Miyatake, T.; B. Tringler, W. Liu, S.H. Liu, J. Papkoff, T. Enomoto, K.C. Torkko, D.L. Dehn, A. Swisher, and K.R. Shroyer. 2007. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol 106: 119-127.
29. Mugler, K.C.; M. Singh, B. Tringler, K.C. Torkko, W. Liu, J. Papkoff, and K.R. Shroyer. 2007. B7-h4 expression in a range of breast pathology: Correlation with tumor T-cell infiltration. Appl Immunohistochem Mol Morphol 15: 363-370.
30. Awadallah, N.S.; K.R. Shroyer, D.A. Langer, K.C. Torkko, Y.K. Chen, J.S. Bentz, J. Papkoff, W. Liu, S.R. Nash, and R.J. Shah. 2008. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas 36: 200-206.
31. Liakou, C.I.; S. Narayanan, D. Ng Tang, C.J. Logothetis, and P. Sharma. 2007. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immun 7: 10.
32. Zang, X.; R.H. Thompson, H.A. Al-Ahmadie, A.M. Serio, V.E. Reuter, J.A. Eastham, P.T. Scardino, P. Sharma, and J.P. Allison. 2007. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A 104: 19458-19463.
33. Krambeck, A.E.; R.H. Thompson, H. Dong, C.M. Lohse, E.S. Park, S.M. Kuntz, B.C. Leibovich, M.L. Blute, J.C. Cheville, and E.D. Kwon. 2006. B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival. Proc Natl Acad Sci U S A 103: 10391-10396.
34. Crispen, P.L.; S.A. Boorjian, C.M. Lohse, B.C. Leibovich, and E.D. Kwon. 2008. Predicting disease progression after nephrectomy for localized renal cell carcinoma: The utility of prognostic models and molecular biomarkers. Cancer 113: 450-460.
35. Yao, Y.; X. Wang, K. Jin, J. Zhu, Y. Wang, S. Xiong, Y. Mao, and L. Zhou. 2008. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells. J Neurooncol 89: 121-129.
36. Jiang, J.; Y. Zhu, C. Wu, Y. Shen, W. Wei, L. Chen, X. Zheng, J. Sun, B. Lu, and X. Zhang. 2010. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunol Immunother 59: 1707-1714.
37. Arigami, T.; Y. Uenosono, M. Hirata, T. Hagihara, S. Yanagita, S. Ishigami, and S. Natsugoe. 2010. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis. J Surg Oncol 102: 748-752.
38. Thompson, R.H.; X. Zang, C.M. Lohse, B.C. Leibovich, S.F. Slovin, V.E. Reuter, J.C. Cheville, M.L. Blute, P. Russo, E.D. Kwon, and J.P. Allison. 2008. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res 68: 6054-6058.
39. Wang, X.; J. Hao, D.L. Metzger, A. Mui, Z. Ao, C.B. Verchere, L. Chen, D. Ou, and G.L. Warnock. 2009. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation 87: 482-490.
40. Wang, X.; J. Hao, D.L. Metzger, A. Mui, Z. Ao, C.B. Verchere, L. Chen, D. Ou, and G.L. Warnock. 2011. B7-H4 induces donor-specific tolerance in mouse islet allografts. Cell Transplant. 21(1): 99-111.
41. Adkisson, H.D.; C. Milliman, X. Zhang, K. Mauch, R.T. Maziarz, and P.R. Streeter. 2010. Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage. Stem Cell Res 4: 57-68.
42. Wang, X.; J. Hao, D.L. Metzger, A. Mui, Z. Ao, N. Akhoundsadegh, S. Langermann, L. Liu, L. Chen, D. Ou, C.B. Verchere, and G.L. Warnock. 2011. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes. 60(12): 3246-55.
43. Xu, J.F.; H. Xiao, G.Y. Hu, S.H. Zheng, W. Liu, C.L. Yuan, H. Yang, J. Lu, F. Zheng, C.Y. Wang, and F.L. Gong. 2010. Ectopic B7-H4-Ig expression attenuates concanavalin A-induced hepatic injury. Clin Immunol 136: 30-41.
44. Chinnadurai, R.; and A. Grakoui. 2010. B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology 52: 2177-2185.
45. Zhu, G.; M.M. Augustine, T. Azuma, L. Luo, S. Yao, S. Anand, A.C. Rietz, J. Huang, H. Xu, A.S. Flies, S.J. Flies, K. Tamada, M. Colonna, J.M. van Deursen, and L. Chen. 2009. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. Blood 113: 1759-1767.
46. Dutsch-Wicherek, M.; R. Tomaszewska, A. Lazar, P. Strek, L. Wicherek, J. Kijowski, and M. Majka. 2010. The presence of B7-H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps - A preliminary report. Folia Histochem Cytobiol 48: 611-617.
47. Kryczek, I.; S. Wei, L. Zou, G. Zhu, P. Mottram, H. Xu, L. Chen, and W. Zou. 2006. Cutting edge: Induction of B7-H4 on APCs through IL-10: Novel suppressive mode for regulatory T cells. J Immunol 177: 40-44.
48. Kryczek, I.; L. Zou, P. Rodriguez, G. Zhu, S. Wei, P. Mottram, M. Brumlik, P. Cheng, T. Curiel, L. Myers, A. Lackner, X. Alvarez, A. Ochoa, L. Chen, and W. Zou. 2006. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203: 871-881.
49. Cao, Q.; Y. Wang, D. Zheng, Y. Sun, V.W. Lee, G. Zheng, T.K. Tan, J. Ince, S.I. Alexander, and D.C. Harris. 2010. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 21: 933-942.
50. Curiel, T.J.; G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, and W. Zou. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
51. Schwarz, A.; and T. Schwarz. 2010. UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype. J Invest Dermatol 130: 1914-1921.
52. Song, H.; G. Park, Y.S. Kim, I. Hur, H. Kim, J.W. Ryu, H.K. Lee, D.H. Cho, I.H. Choi, W.J. Lee, and D.Y. Hur. 2008. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation. Cancer Lett 266: 227-237.
53. Chang, F.; J.T. Lee, P.M. Navolanic, L.S. Steelman, J.G. Shelton, W.L. Blalock, R.A. Franklin, and J.A. McCubrey. 2003. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia 17: 590-603.
54. Steelman, L.S.; S.C. Pohnert, J.G. Shelton, R.A. Franklin, F.E. Bertrand, and J.A. McCubrey. 2004. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18: 189-218.